Public health authorities said Wednesday they were accelerating a review of the controversial Dengvaxia dengue vaccine's efficiency after its use was halted in the Philippines last week. Last week, the Department of Health in the Philippines suspended the use of Dengvaxia produced by French drug giant Sanofi. Public Health Minister Piyasakol Sakolsatayadorn also said the ministry has not actually focused on the use of a dengue vaccine as a key means of preventing the disease. As for people who have already received dengue vaccine shots, he said, they should not worry too much about the possible side effects that have been reported in the news because not everyone will develop them. The DDC is implementing a surveillance programme on possible dengue vaccine side effects and discussing and developing guideline on administering the jab, said the minister.

Source: Bangkok Post December 06, 2017 22:30 UTC